ABSTRACT Introduction: Proton Pump inhibitors (PPIs) are commonly used for a variety of
acid related disorders. Despite the overall effectiveness and safety profile of PPIs, some …

Proton pump inhibitors (PPIs) reliably suppress gastric acid secretion and are therefore the
first‐line treatment for gastric acid‐related disorders. Hypomagnesemia (serum magnesium …

1.1. Термины и определение Болезнь Крона (БК)–хроническое, рецидивирующее
заболевание желудочно-кишечного тракта неясной этиологии, характеризующееся …

Background & Aims For decades, proton pump inhibitors (PPIs) have been the mainstay of
treatment for erosive esophagitis. The potassium-competitive acid blocker vonoprazan …

Recommendations of the Russian Gastroenterological Association in Diagnosis and
Treatment of Gastroesophageal Reflux Disease | Ivashkin | Russian Journal of …

Аннотация Цель. Настоящие рекомендации Российской гастроэнтерологической
ассоциации разработаны с целью ознакомления практикующих врачей с …

The number of patients with gastroesophageal problems taking proton pump inhibitors
(PPIs) is increasing. Several studies suggested a possible association between PPIs and …

Conventional proton pump inhibitors (PPIs) are used as a first-line therapy to treat acid-
related diseases worldwide. However, they have a number of limitations including slow …

Many viruses utilize the host endo-lysosomal network for infection. Tracing the endocytic
itinerary of SARS-CoV-2 can provide insights into viral trafficking and aid in designing new …

The synthesis of new compounds with antimicrobial and antiviral properties is a central
objective today in the context of the COVID-19 pandemic. Benzimidazole and pyrazole …